SynthesisFrontiers in immunology2024

Reporting quality and risk of bias of randomized controlled trials of Chinese herbal medicine for multiple sclerosis.

Jing-Ying Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.